Pyridinonyl pdk1 inhibitors

John J. Gaudino, Allison L. Marlow, Allen A. Thomas, Meese Jason De, Hongqi Tian, James F. Blake, Steven Boyd, Jeongbeob Seo, Heterobicyclic thiophene compounds for the treatment of cancer ,(2007)

Michele Pothashman, Aaron C. Siegmund, Derin D'amico, Ning Xi, Deborah Choquette, Philip Roveto, Steven Bellon, Daniel La, Longbin Liu, Matthew Lee, Julie Germain, Noel D'angelo, Tae-Seong Kim, Satoko Hirai, Shon Booker, David Bauer, Jean-Cristophe Harmange, Russel Graceffa, Mark H. Normal, Celia Dominguez, Ingrid M. Fellows, Kevin Yang, Alessandro Boezio, Substituted amide derivatives as protein kinase inhibitors ,(2006)

Paul J. T. Missel, John C. Lang, Rajni Jani, Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions ,(1992)

Volker Hitzel, Karl Geisen, Werner Pfaff, Rudi Weyer, Certain nicotinamido-n-benzoic acid derivatives ,(1978)

Wing C. Tom, Margaret H. Scherlock, Substituted 1-H-pyrrolopyridine-3-carboxamides ,(1990)

Craig Marhefka, Jeremy Green, Phthalimide compounds useful as protein kinase inhibitors ,(2004)

David Ian Carter Scopes, Stephen Martin Courtney, Philip Andrew Hay, Benzoxazole, benzthiazole and benzimidazole acid derivatives and their use as heparanase inhibitors ,(2003)

Hitesh Sanganee, Roger Bonnert, Peter Sjö, Grigorios Nikitidis, Fraser Hunt, Dan Warner, Rupert Austin, Pyridopyrimidine derivatives and their use as pde4 inhibitors ,(2007)

Ping Chen, Yufen Zhao, Brian E Fink, Soong-Hoon Kim, Pyrrolotriazine kinase inhibitors ,(2007)

Marie-Claire Friteyre, Claude Mazuel, Ophthalmological composition of the type which undergoes liquid-gel phase transition ,(1986)